• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

451
81
51
50
31

COUNTRY

48
19
6
6
6

PRICE

288
481
1,092
1,547

PUBLISHED

66
102
368
1,547

PRODUCT TYPE

1,526
14
5
2

Central Nervous System

(1,547 Products)

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

February 2015
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

July 2015
FROM

Global Anxiety Disorders Market 2015-2019

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response....

January 2015
FROM
Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market- Forecasts till 2019 Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market- Forecasts till 2019 - Product Thumbnail Image

Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market- Forecasts till 2019

Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve...

February 2015
FROM
Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014  Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014 - Product Thumbnail Image

Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014

REPORT DESCRIPTION This report is a comprehensive analysis and market study of new developments relating to early-stage minimally-invasive biomarkers in Alzheimer's disease, which have been 'functionally...

August 2014
FROM
Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers:  New Developments, Growth Areas and Opportunities - Product Thumbnail Image

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental minimally-invasive...

September 2014
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

July 2015
FROM

Internal Neurostimulation Market, by Type, by Application, and by Geography – Analysis & Forecasts to 2019

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application (Parkinson’s...

April 2015
FROM

EpiCast Report: Fibromyalgia - Epidemiology Forecast to 2023

EpiCast Report: Fibromyalgia - Epidemiology Forecast to 2023 Summary Fibromyalgia, also known as fibromyalgia syndrome and fibrositis, is a common form of nonarticular rheumatism that is associated...

May 2015
FROM
Inhaled CNS Therapeutics Inhaled CNS Therapeutics - Product Thumbnail Image

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

June 2014
FROM

Brain Monitoring Market [By Product [EEG/Magnetoencephalography (MEG)/ Intracranial Pressure Monitor/Cerebral Oximeter/ Transcranial Doppler] & Application [Sleep Disorders/ Epilepsy/Traumatic Brain Injury/Brain Death] – Global Forecasts to 2017

The global brain monitoring devices market was valued at $1 08 billion in 2012, and is poised to grow at a CAGR of 8 6% to reach $1 63 billion by 2017 The market offers a variety of brain monitoring...

February 2013
FROM
Latuda-Drug Insights,2014 Latuda-Drug Insights,2014 - Product Thumbnail Image

Latuda-Drug Insights,2014

“Latuda - Drug Insights, 2014” provides Latuda marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

July 2015
FROM
Neurontin-Drug Insights,2014 Neurontin-Drug Insights,2014 - Product Thumbnail Image

Neurontin-Drug Insights,2014

“Neurontin - Drug Insights, 2014” provides Neurontin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

July 2015
FROM
Subridion-Drug Insights,2014 Subridion-Drug Insights,2014 - Product Thumbnail Image

Subridion-Drug Insights,2014

“Subridion - Drug Insights, 2014” provides Subridion marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

July 2015
FROM
Xanax-Drug Insights,2014 Xanax-Drug Insights,2014 - Product Thumbnail Image

Xanax-Drug Insights,2014

“Xanax XR - Drug Insights, 2014” provides Xanax XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

July 2015
FROM
Maxalt-Drug Insights,2014 Maxalt-Drug Insights,2014 - Product Thumbnail Image

Maxalt-Drug Insights,2014

“Maxalt - Drug Insights, 2014” provides Maxalt marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

July 2015
FROM
Risperdal Consta LP-Drug Insights,2014 Risperdal Consta LP-Drug Insights,2014 - Product Thumbnail Image

Risperdal Consta LP-Drug Insights,2014

“Risperdal Consta LP - Drug Insights, 2014” provides Risperdal Consta LP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

July 2015
FROM
Xeroquel LP-Drug Insights,2014 Xeroquel LP-Drug Insights,2014 - Product Thumbnail Image

Xeroquel LP-Drug Insights,2014

“Xeroquel LP - Drug Insights, 2014” provides Xeroquel LP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

July 2015
FROM
Rebif-Drug Insights,2014 Rebif-Drug Insights,2014 - Product Thumbnail Image

Rebif-Drug Insights,2014

“Rebif - Drug Insights, 2014” provides Rebif marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

July 2015
FROM
Plavix-Drug Insights,2014 Plavix-Drug Insights,2014 - Product Thumbnail Image

Plavix-Drug Insights,2014

“Plavix - Drug Insights, 2014” provides Plavix marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

July 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.